Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Presence of telomerase activity with undetectable p16 gene mutation in Malaysian patients with brain tumor.

Jafri AM, Sarina S, George PJ, Nizam IM.

Med J Malaysia. 2004 Oct;59(4):480-5.

2.

Homozygous deletion of the p16/MTS-1/CDKN2 gene in malignant gliomas is infrequent among Japanese patients.

Mochizuki S, Iwadate Y, Namba H, Yoshida Y, Yamaura A, Sakiyama S, Tagawa M.

Int J Oncol. 1999 Nov;15(5):983-9.

PMID:
10536183
3.

Telomerase activity in Malaysian patients with central nervous system tumors.

Isa MN, Sulong S, Sidek MR, George PJ, Abdullah JM.

Southeast Asian J Trop Med Public Health. 2003 Dec;34(4):872-6.

PMID:
15115103
4.

Telomerase activity and homozygous deletions of the p16 gene in liver metastases of colorectal carcinoma.

Ma J, Zhan W, Peng J, He Y, Zheng Z, Cai S, Wang L, Wang J.

Chin Med J (Engl). 2001 Oct;114(10):1068-72.

PMID:
11677769
5.

Telomerase activation and p53 mutations in urethane-induced A/J mouse lung tumor development.

Ohno J, Horio Y, Sekido Y, Hasegawa Y, Takahashi M, Nishizawa J, Saito H, Ishikawa F, Shimokata K.

Carcinogenesis. 2001 May;22(5):751-6.

PMID:
11323394
6.

[Analysis on point mutation of the CDKN2/p16 gene in lung cancer].

Su C, Ye Y, Wang D, Cao X, Li S, Shan X.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Feb;19(1):37-40. Chinese.

PMID:
11836684
7.

Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.

Oishi T, Kigawa J, Minagawa Y, Shimada M, Takahashi M, Terakawa N.

Obstet Gynecol. 1998 Apr;91(4):568-71.

PMID:
9540942
8.

Association of p53 tumor suppressor gene with paraclinical and clinical modalities of gliomas patients in Malaysia.

Yusoff AA, Abdullah J, Abdullah MR, Mohd Ariff AR, Isa MN.

Acta Neurochir (Wien). 2004 Jun;146(6):595-601. Epub 2004 Apr 8.

PMID:
15168228
9.

Molecular genetic analysis of phosphatase and tensin homolog and p16 tumor suppressor genes in patients with malignant glioma.

Abdullah JM, Zainuddin N, Sulong S, Jaafar H, Isa MN.

Neurosurg Focus. 2003 Apr 15;14(4):e6.

PMID:
15679305
10.

[Changes of p16 gene, cyclin D1 gene, and pRb protein in human pancreatic adenocarcinoma cell lines].

Xu Y, Chen J, Liu T, Gu L, Gao J, Li L.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Dec;22(6):566-9. Chinese.

PMID:
12903406
11.

Mutations of the p53 gene in gliomas from Malay patients.

Jafri A, Aziz MY, Ros S, Nizam I.

Med J Malaysia. 2003 Jun;58(2):236-42.

12.
13.

Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15.

Soto Martínez JL, Cabrera Morales CM, Serrano Ortega S, López-Nevot MA.

Clin Transl Oncol. 2005 May;7(4):156-64.

PMID:
15960923
15.

Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.

Papageorgiou SG, Pappa V, Papageorgiou E, Tsirigotis P, Kontsioti F, Panani A, Dervenoulas J, Economopoulos T.

Eur J Haematol. 2005 Sep;75(3):193-8.

PMID:
16104874
16.
17.

p16/INK4a gene methylation is a frequent finding in pulmonary MALT lymphomas at diagnosis.

Takino H, Okabe M, Li C, Ohshima K, Yoshino T, Nakamura S, Ueda R, Eimoto T, Inagaki H.

Mod Pathol. 2005 Sep;18(9):1187-92.

18.

Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.

Kawai J, Kodera Y, Fujiwara M, Kasai Y, Nagasaka T, Koike M, Hibi K, Ito K, Akiyama S, Nakao A.

Hepatogastroenterology. 2005 May-Jun;52(63):959-64.

PMID:
15966241
19.

Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcoma.

Park YK, Cho CH, Chi SG, Han CS, Ushigome S, Unni KK.

Int J Oncol. 2001 Oct;19(4):749-53.

PMID:
11562750
20.

Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation.

Trojani A, Ripamonti CB, Penco S, Beghini A, Nadali G, Di Bona E, Viola A, Castagnola C, Colapietro P, Grillo G, Pezzetti L, Ravelli E, Patrosso MC, Marocchi A, Cuneo A, Ferrara F, Lazzarino M, Pizzolo G, Cairoli R, Morra E.

Anticancer Res. 2008 Sep-Oct;28(5A):2745-51.

Supplemental Content

Support Center